NOVEL COMBINATORIAL TARGETED CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELL-BASED CELLULAR IMMUNOTHERAPY WITH ADJUVANT IMMUNOMODULATION IN PATIENTS WITH AML
$1,441,140FY2021Defense Health AgencyDOD
New York Medical College, Valhalla NY
New York Medical College, Valhalla NY